- Companies
- ContextVision
ContextVision Valuation Multiples
ContextVision is valued at $36M as of October 2026, a 2.3x revenue multiple. In the last 12 months, ContextVision revenue was $12M and ContextVision EBITDA was $2M.
ContextVision Overview
About ContextVision
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.
Founded
1983
HQ
Employees
40
Website
Financials (LTM)
EV
$29M
Valuation Multiples
Start free trialContextVision Financials
ContextVision reported last 12-month revenue of $12M and EBITDA of $2M.
In the same LTM period, ContextVision generated $2M in EBITDA and $88K in net income.
Revenue (LTM)
ContextVision P&L
In the most recent fiscal year, ContextVision reported revenue of $11M and EBITDA of $633K.
ContextVision is profitable as of last fiscal year, with gross margin of 97%, EBITDA margin of 6%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
ContextVision Stock Performance
ContextVision has current market cap of $36M, and enterprise value of $29M.
Market Cap Evolution
ContextVision's stock price is $0.49.
ContextVision share price decreased by 13.9% in the last 30 days, and increased by 15.0% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $29M | $36M | 0.0% | -13.9% | 36.4% | 15.0% | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialContextVision Valuation Multiples
ContextVision trades at 2.3x EV/Revenue multiple, and 12.3x EV/EBITDA.
EV / Revenue (LTM)
ContextVision Financial Valuation Multiples
As of October 19, 2026, ContextVision has market cap of $36M and EV of $29M.
ContextVision has a P/E ratio of 412.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ContextVision Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


ContextVision Margins & Growth Rates
ContextVision grew revenue by 11% and EBITDA by 289% in the last fiscal year.
In the most recent fiscal year, ContextVision reported gross margin of 97%, EBITDA margin of 6%, and net margin of 1%.
ContextVision Margins
ContextVision Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
ContextVision Operational KPIs
ContextVision's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.
ContextVision's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
ContextVision's Rule of X is 48% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
ContextVision Competitors
ContextVision competitors include Star Equity Holdings, Mach7 Technologies, Nano X Imaging, Singular Health, PharmX Technologies, SMAIO, Rocket Doctor AI, Insung Information, Cyclopharm and Novacyt.
Most ContextVision public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, HealthTech and Vertical SaaS.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $172M | ($2M) | 0.3x | 0.3x | (26.2x) | 8.6x | |||
| $14M | ($1M) | 1.5x | 1.2x | (21.2x) | (11.4x) | |||
| $13M | ($67M) | 0.9x | 0.7x | (0.2x) | - | |||
| $992K | ($5M) | 30.7x | 17.5x | (6.6x) | (10.2x) | |||
| $5M | ($142K) | 7.1x | - | (264.5x) | - | |||
| $10M | ($1M) | 3.5x | 3.4x | (33.7x) | (17.3x) | |||
| $1M | ($10M) | 28.8x | 16.4x | (3.6x) | (3.3x) | |||
| $256M | ($648K) | 0.1x | - | (53.3x) | - | |||
This data is available for Pro users. Sign up to see all ContextVision competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ContextVision
| When was ContextVision founded? | ContextVision was founded in 1983. |
| Where is ContextVision headquartered? | ContextVision is headquartered in Sweden. |
| How many employees does ContextVision have? | As of today, ContextVision has over 40 employees. |
| Is ContextVision publicly listed? | Yes, ContextVision is a public company listed on Oslo Børs. |
| What is the stock symbol of ContextVision? | ContextVision trades under CONTX ticker. |
| When did ContextVision go public? | ContextVision went public in 1997. |
| Who are competitors of ContextVision? | ContextVision main competitors include Star Equity Holdings, Mach7 Technologies, Nano X Imaging, Singular Health, PharmX Technologies, SMAIO, Rocket Doctor AI, Insung Information, Cyclopharm, Novacyt. |
| What is the current market cap of ContextVision? | ContextVision's current market cap is $36M. |
| What is the current revenue of ContextVision? | ContextVision's last 12 months revenue is $12M. |
| What is the current revenue growth of ContextVision? | ContextVision revenue growth (NTM/LTM) is (0%). |
| What is the current EV/Revenue multiple of ContextVision? | Current revenue multiple of ContextVision is 2.3x. |
| What is the current EBITDA of ContextVision? | ContextVision's last 12 months EBITDA is $2M. |
| What is ContextVision's EBITDA margin? | ContextVision's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of ContextVision? | Current EBITDA multiple of ContextVision is 12.3x. |
| What is the current FCF of ContextVision? | ContextVision's last 12 months FCF is $88K. |
| What is ContextVision's FCF margin? | ContextVision's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of ContextVision? | Current FCF multiple of ContextVision is 330.0x. |
| How many companies ContextVision has acquired to date? | ContextVision hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies ContextVision has invested to date? | ContextVision hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to ContextVision
Lists including ContextVision
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




